Loading...
OTC Markets
Totals
Securities
12,312
Dollar Vol
$1.9B
Share Vol
3.6B
Trades
351,892

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

CBWTF
Auxly Cannabis Group Inc.

Ordinary Shares

0.087

-0.0083

-8.71%

0.085 / 0.0882 (54000 x 10000)

Real-Time Best Bid & Ask: 05:00pm 07/14/2025
Delayed (15 Min) Trade Data: 03:59pm 07/14/2025

Auxly Cannabis Group Inc.

777 Richmond Street W.,

Suite 002

Toronto, ON M6J0C2

Canada

Principal Executive Offices:

777 Richmond Street W.,

Suite 002

Toronto, ONT M6J0C2

Canada

Business Description
Auxly Cannabis Group Inc. operates as a vertically integrated cannabis company.
Financial Reporting
Reporting Status
International Reporting: Toronto Stock Exchange
Audited Financials
Audited
Fiscal Year End
12/31
Company Officers & Contacts
Hugo Alves
CEO

Michael Lickver
President

Travis Wong
CFO

Accounts Payable
Accountant

Board of Directors
Genevieve Young
Chairman, Independent Director, Audit Committee Member, Compensation Committee Member

Hugo Alves
CEO

Vikram Bawa
Independent Director, Compensation Committee Member

Troy James Grant
Independent Director, Audit Committee Member, Compensation Committee Member

As the Founder & CEO of the company Mr. Grant took the company public in June 2011. Since then, Mr. Grant lead the company through many accomplishments: the Uptake Project for Ragedara mine is on time and within budget, advancing in Graphene R&D and establishing Graphene Corp as a subsidiary of Elcora, as well as securing millions of dollars of investments.

Conrad Tate
Independent Director, Audit Committee Member, Compensation Committee Member

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
EY.

100 Adelaide St. W

P.O. Box 1

Toronto, ON M5H 0B3

Canada

Securities Counsel
Owens Wright LLP

20 Holly Street

Toronto, ON M4S 3B1

Canada

Profile Data
SIC - Industry Classification
8099 - Health and allied services, misc
Incorporation Information
ON, CA, 2017
Employees
380 as of 12/31/2024
Shell
No
Products and Services

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Company Facilities

Auxly Charlottetown is a 52,000 sq ft facility located in Price Edward Island. This is the Company’s centre for cannabis product formulation and manufacturing including extraction and R&D activities. Auxly Leamington is a 1.1 million sq ft greenhouse cultivation facility located in Leamington, ON in which ~770,000 sq ft of the facility is licensed for cultivation, manufacturing and distribution of the Company’s dried flower cannabis products.

Company Notes
Formerly=Cannabis Wheaton Income Corp. until 6-2018
Formerly=Knightswood Financial Corp. until 5-2017
Formerly=First Venture Developments Ltd. until 12-98
OTCQB Venture Market Logo
Joined OTCQB 01/2023
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.